"Turpentine VC" | Venture Capital and Investing cover image

E61: Rabois, Bartlett, Ryan, and Weinberg on AI, Gambling, and Healthcare

"Turpentine VC" | Venture Capital and Investing

00:00

Navigating the FDA's Approval Labyrinth

This chapter explores the intricate balance of safety and timely access in the FDA's drug approval process, emphasizing the ethical dilemmas inherent in pharmaceutical decisions. It highlights specific cases, such as Pfizer's withdrawal of a sickle cell treatment, to illustrate the risks involved in drug development and distribution. The discussion also encourages a critical evaluation of personal responsibility and the understanding of medical risks in healthcare.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app